Strategic Vigilance and Incident Management for Brazil

Regulatory Oversight of ANVISA

The supervision of medical device safety within the Brazilian market is the primary responsibility of the National Health Surveillance Agency which is commonly referred to as ANVISA. Manufacturers and distributors must participate in a technovigilance system designed for continuous post-market monitoring and the execution of field safety corrective actions. Regulatory frameworks such as Resolution RDC No. 67/2009 and Resolution RDC No. 551/2021 provide the legal basis for terminology and mandatory reporting timeframes. Failure to accurately disclose safety incidents can lead to severe legal penalties for the responsible parties.

Criteria for Notifying Authorities of Incidents

A safety event must be formally disclosed to the National Sanitary Surveillance System (SNVS) if a device malfunction or improper use leads to specific negative consequences.

• Events resulting in the death or serious health deterioration of a patient or user must be reported.
• Incidents that could potentially lead to serious harm or death if they were to happen again are also subject to disclosure.
• Any other applicable circumstances specified under local Brazilian law require formal notification.

The legal responsibility for communicating these events is shared between the manufacturer and the designated Brazil Registration Holder (BRH). Additionally, certain types of recurring issues may necessitate the filing of a Technical Complaint under defined conditions.

Execution of Field Safety and Market Actions

Manufacturers must proactively notify ANVISA whenever it is determined that a field safety action or a product recall is required to mitigate risks of serious injury or death. This process includes issuing an official alert to the authority and ensuring that corrective information is distributed to consumers.

Administrative Steps for Reporting to ANVISA

The submission of safety data involves a structured coordination between the manufacturer and the local regulatory infrastructure.

• Determining the correct notification window is essential and depends on the severity of the event as outlined in RDC No. 67/2009 and RDC No. 551/2021.
• The BRH and the SNVS must be alerted immediately once a reportable incident has been verified.
• Both the BRH and ANVISA must be informed if the situation justifies a field safety intervention.
• Official notification to ANVISA must be finalized within the legal timeframe applicable to the specific nature of the occurrence.
• Detailed alert messages must be sent to consumers to explain the necessary corrective steps.
• Final summaries and monitoring reports regarding the adverse event must be provided to both SNVS and ANVISA.
• All vigilance records should be integrated into the company's technical files or quality system according to industry standards.

Responsibilities of the Brazil Registration Holder

For international manufacturers, the BRH serves as the mandatory legal liaison within the country. This representative is responsible for filing adverse event reports and coordinating all recall-related data with the SNVS on behalf of the manufacturer. Maintaining a professional presence in Brasilia ensures that incidents are reported with technical accuracy and that the company satisfies its ongoing post-market obligations.

Proregulations' Brazil Post-market Safety Services

Our team facilitates compliance with ANVISA's technovigilance requirements through the following specialized service modules.

• Legal BRH and representative services
  We act as your officially designated registration holder in Brazil to manage mandatory safety notifications and serve as the primary contact for ANVISA communications.
• Adverse event evaluation and technical filing
  Our experts analyze potential incidents to determine reportability and ensure that technical complaints are submitted within the required legal windows.
• Field safety intervention and recall management
  We assist in planning and executing market actions, including the preparation of consumer alert messages to meet risk mitigation expectations.
• Vigilance procedure monitoring and alignment
  Our consultants keep your monitoring protocols updated in accordance with the latest RDC resolutions and Brazilian legislative changes.
• Quality documentation and audit preparation
  We ensure that all safety reports and vigilance data are properly recorded within your technical files to support future regulatory inspections.

If you are interested in our Brazil ANVISA vigilance reporting services and wish to secure your market position, please feel free to contact us.